Amylyx Pharmaceuticals
AMLX
#7475
Rank
C$0.42 B
Marketcap
$4.74
Share price
-3.61%
Change (1 day)
29.57%
Change (1 year)

Amylyx Pharmaceuticals (AMLX) - Cash on Hand

Cash on Hand as of December 2024 : C$0.25 Billion

According to Amylyx Pharmaceuticals's latest financial reports the company has C$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Amylyx Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.25 B-48.58%
2023-12-31C$0.49 B4.62%
2022-12-31C$0.47 B284.33%
2021-12-31C$0.12 B646.06%
2020-12-31C$16.41 M310.16%
2019-12-31C$4 M